MRDadaptis: Self-Adaptive Parameter Configuration Enhances Minimal Residual Disease Detection in Heterogeneous ctDNA Samples
Tianci WangiD, Xin LaiiD, Shenjie Wang, Zhengfa XueiD, Yuqian LiuiD, Xiaoyan ZhuiD, Xiaonan WangiD, Zhili Chang, Yang Washington ShaoiD, Xian ZhangiD, Jiayin WangiD
Abstract
Detection of structural variations (SV) through circulating tumor DNA (ctDNA) has become a key method for detecting minimal residual disease (MRD). However, the heterogeneity of ctDNA samples, characterized by variable limits of detection (LOD) and diverse structural variant types, significantly impacts detection stability and consistency, posing persistent challenges for conventional SV detection tools such as Delly and Manta. These widely-used methods require extensive manual parameter tuning, hindered by the combinatorial complexity of multiple parameters and heterogeneous sequencing data. To address this, we propose MRDadaptis, a novel SV detection tool that uniquely incorporates a self-adaptive parameter optimization mechanism. MRDadaptis distinguishes itself by integrating Bayesian optimization with meta-learning techniques to dynamically adjust detection parameters automatically, based on intrinsic features derived from the ctDNA sequencing data itself. This innovative approach not only reduces manual intervention but also effectively captures sample-specific characteristics, significantly improving detection stability and detection performance. Extensive validation experiments using both simulated and real-world ctDNA datasets demonstrates MRDadaptiss distinct advantages, including markedly improved average F1-scores and superior stability (reduced variance, lower RMSE, increased kurtosis) These results highlight the significant advantages of MRDadaptis in addressing sample heterogeneity, underscoring its potential to improve the accuracy and reliability of MRD detecting through ctDNA analysis. https://github.com/aAT0047/MRDadaptis.git
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.90
- Field percentile
- top 27%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- ctDNAtools: An R package to work with sequencing data of circulating tumor DNA
Amjad Alkodsi, Leo Meriranta, … Sirpa Leppä·bioRxiv·Jan 27, 2020
- BayVarC: an ultra-sensitive ctDNA variant caller using Bayesian approach
Dongxue Che, Cheng Yan, … Yu-Fei Yang·bioRxiv·Feb 3, 2024
- Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis
Bradon R. McDonald, Tania Contente‐Cuomo, … Muhammed Murtaza·Science Translational MedicinePeer-reviewed·Aug 7, 2019
- TNER: A Novel Background Error Suppression Method for Mutation Detection in Circulating Tumor DNA
Shibing Deng, Maruja Lira, … Tao Xie·BMC BioinformaticsPeer-reviewed·Oct 20, 2018
- High-sensitivity monitoring of ctDNA by patient-specific sequencing panels and integration of variant reads
J. C. Wan, K. Heider, … N. Rosenfeld·bioRxiv·Sep 11, 2019
- Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
Adam J. Widman, Minita J. Shah, … Dan Avi Landau·Nature MedicinePeer-reviewed·Jun 1, 2024